share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

SEC announcement ·  Apr 2 01:36
Summary by Futu AI
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.